Grantham, Mayo, Van Otterloo & Co (GMO)’s NCR Voyix VYX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio VYX Stock Details VYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,970	Closed	-$255K	–	857
2021 Q1	$255K	Buy	+10,970	New	+$241K	﹤0.01%	797
2020 Q2	–	Sell	-67,867	Closed	-$737K	–	833
2020 Q1	$737K	Buy	67,867 +34,882	+106%	+$599K	0.01%	546
2019 Q4	$711K	Buy	+32,985	New	+$642K	﹤0.01%	556
2017 Q4	–	Sell	-158,925	Closed	-$3.66M	–	637
2017 Q3	$3.66M	Buy	158,925 +138,224	+668%	+$3.18M	0.02%	262
2017 Q2	$519K	Buy	20,701 +12,225	+144%	+$310K	﹤0.01%	412
2017 Q1	$238K	Buy	+8,476	New	+$232K	﹤0.01%	480

Other funds holding VYX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CAM

Contour Asset Management New York $4.22B AUM 26.55% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s VYX Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of NCR Voyix (VYX) in Q2 2021, closing a stake of 10,970 shares — an estimated $255K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VYX in Q1 2017 and held it in 6 quarters. The position peaked at $3.66M in Q3 2017. 397 funds tracked by Wall St. Rank hold VYX as of Q2 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining NCR Voyix position as of Q2 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,970 NCR Voyix shares in Q2 2021, an estimated $255K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NCR Voyix in Q1 2017 and held it in 6 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s NCR Voyix position peaked at $3.66M in Q3 2017.
397 funds tracked by Wall St. Rank held NCR Voyix as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.